SPECIAL NOTICE
99 -- Custom Synthesis of 9 Antisense Oligonucleotides (ASOs) for Neurtox Study
- Notice Date
- 7/20/2023 3:53:16 PM
- Notice Type
- Special Notice
- NAICS
- 325414
— Biological Product (except Diagnostic) Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH Bethesda MD 20892 US
- ZIP Code
- 20892
- Solicitation Number
- 75N95023Q00539
- Response Due
- 7/25/2023 10:00:00 AM
- Archive Date
- 08/09/2023
- Point of Contact
- Michelle Cecilia, Phone: 3018277199
- E-Mail Address
-
michelle.cecilia@nih.gov
(michelle.cecilia@nih.gov)
- Description
- PRE-SOLICITATION NOTICE OF INTENT NON-COMPETITIVE Notice of Intent: 75N95023Q00539 INTRODUCTION PURSUANT TO FAR Subpart 5.2�Synopses of Proposed Contract Actions, THIS IS A PRE- SOLICITATION NOTICE OF A PROPOSED CONTRACT TO ACTION. THIS IS A PRE-SOLICITATION NON-COMPETITIVE NOTICE OF INTENT TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisitions, on behalf of the National Center for Advancing Translational Sciences (NCATS) intends to negotiate and award a contract to Integrated DNA Technologies, Inc. (IDTDNA) 1710 Commercial park, Coralville, IA 52241 for the Custom Synthesis of 9 Antisense Oligonucleotids (ASOs). NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS Code 325414: Biological Product with a Size Standard of $1,250 employees. Set-aside Status: Small Business set-aside restriction is not applicable. Competition Status: �This requirement is posted as non-competitive. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses of the Federal acquisition Regulation (FAR) in effect through the Federal Acquisition Circular 2023-04, dated June 2, 2023. STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13�Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single �source. IDT DNA will synthesize and deliver 9 antisense oligonucleotides as a test case for treating rare diseases with specific requirements that is only available from IDTNDA. �IDTDNA is recognized as the first company to initiate ASO synthesis and is a leader in research-grade antisense oligonucleotide synthesis. IDTDNA has provided the necessary and unique support services and expertise for the ASO design. The company uses proprietary oligonucleotide synthesis machines that provide the very highest accuracy in terms of the oligonucleotide sequence provided to NCATS. IDTDNA is the only source for the required ASOs as they were the ones who provided the original material at the inception of the study. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. The respondents must submit clear and convincing evidence that their product is equivalent or superior to the product specified in this notice. The response shall include: the unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered to determine the method of acquisition. The response must also indicate the country of manufacturer of components and country of assembly (not necessary for IT and Maintenance purchases). A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non- competitive basis or to conduct a competitive procurement. All responses must be received by July 25, 2023 at 1:00 PM Eastern Time and must �reference number 75N95023Q00539. Responses must be submitted electronically to Michelle Cecilia, Contracting Officer, at michelle.cecilia@nih.gov, and must reference the solicitation number 75N95023Q00539 , on y our electronic request. FAX requests are not accepted. �All responsible sources may submit a capability statement, proposal, or quotation, which shall �be considered by the agency.� �
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/326ddb26f0e248bab3db9e1b417117c5/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06756695-F 20230722/230720230048 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |